GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Bendamustine (Belrapzo), IV solution for dilution

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Belrapzo - labeled renal guidance

Product / population
Bendamustine (Belrapzo), IV solution for dilution
Renal method
Creatinine clearance (CrCl), mL/min; use the product-specific calculation
Source revision
DailyMed SPL version 11, effective 2024-09-23; posted Oct 03, 2024
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Belrapzo - product and source limitations

Confirm this formulation before applying preparation and infusion instructions.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Belrapzo - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Bendamustine (Belrapzo), IV solution for dilution

Renal method: Creatinine clearance (CrCl), mL/min; use the product-specific calculation
Source date: DailyMed SPL version 11, effective 2024-09-23; posted Oct 03, 2024
Retrieved: 2026-11-07

Restriction or avoidance guidance. Read the specific threshold, age, formulation and dialysis exclusions; do not generalize across products.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: 8.6

Do not use Belrapzo at CrCl below 30 mL/min. Confirm this formulation before applying preparation and infusion instructions.

RDM73-belrapzo-official-1 · Source locator: Renal guidance: 8.6

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9759a4ae-82ca-40cf-9c02-e1cadb21cbdc
Retrieved
2026-11-07
Renal-function method
Creatinine clearance (CrCl), mL/min; use the product-specific calculation
Source date/version
DailyMed SPL version 11, effective 2024-09-23; posted Oct 03, 2024
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
63b02f6ea3d8c4f89a53c36cc9ed3070ff1a39d824c1e88a88c3ed1fa1fa2f9d

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=bendamustine-belrapzo&s1=RDM73-belrapzo-official&h1=1ac5e48f6f5f2685185144ba7afa05137862935582e26fe5a24749fc9e79891d

Top